Serum Uromodulin and DN Systematic Review and Meta Analysis
Association of Serum Uromodulin and DKD a Systematic Review and Meta Analysis
1 other identifier
observational
1,774
1 country
1
Brief Summary
Several studies have investigated the association between the changes of serum uromodulin and diabetic nephropathy (DN). However, the results are still controversial. Hence, this meta-analysis aimed to evaluate the association of uromodulin with DN.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedFirst Submitted
Initial submission to the registry
September 11, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 19, 2024
September 1, 2024
29 days
September 11, 2024
September 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association of serum uromodulin with DKD: asystematic review and meta analysis
Evaluate the meta analysis of association of serum uromodulin in the 3 diabetic group comparing with each other and compare them to the control group and correlate these results with other kidney biomarker
may, 2024
Study Arms (2)
Control group
Included 862 healthy subjects as control group
DKD group
Included 912 patients with DN
Interventions
Meta analysis of association of serum uromodulin with DKD
DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
Eligibility Criteria
The systematic search strategy retrieved 275 publications by the 4 databases (PubMed 76, Cochrane Library 11, Web of Science 107, and Scopus 81). 144 studies remained after exclusion the duplicates. After screening title and abstract 135 studies were excluded. 9 studies remained for full text and data reviewing. 4 studies of them were excluded as they didn't meet the eligibility criteria. In addition, 1 study was retrieved by manual search from Google Scholar. Finally, 6 articles were included \[20-25\]. The selected studies included 1774 participant
You may qualify if:
- Studies were included if they met the following criteria:
- serum level of uromodulin was determined;
- the samples were enrolled from diabetic patients;
- mean ± SD was reported for uromodulin between patients with and without DN;
- the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN was determined
You may not qualify if:
- Studies were excluded according to the following criteria:
- duplicate studies;
- review articles;
- non original research articles;
- studies with insufficient data to extract;
- non-human research;
- studies that determined urine level of uromodulin.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tanta Universitylead
- Ain Shams Universitycollaborator
Study Sites (1)
Tanta Yniversity
Tanta, Yes, 31511, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr of Biochemistry
Study Record Dates
First Submitted
September 11, 2024
First Posted
September 19, 2024
Study Start
May 1, 2024
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share